A Systematic Comparison of Cockcroft-Gault and Modification of Diet in Renal Disease Equations for Classification of Kidney Dysfunction and Dosage Adjustment

被引:41
作者
Park, Eun Jung [1 ]
Wu, Kunyi [1 ]
Mi, Zenghui [1 ]
Dong, Ting [1 ]
Lawrence, John P. [2 ]
Ko, Chia-Wen [2 ]
Huang, Shiew-Mei [3 ]
Zhang, Lei [3 ]
Crentsil, Victor [4 ]
Zhang, Jialu [2 ]
Xu, Nancy N.
机构
[1] US FDA, Div Cardiovasc & Renal Prod, Off New Drugs, Ctr Drug Evaluat & Res, Silver Spring, MD USA
[2] US FDA, Off Biostat, Ctr Drug Evaluat & Res, Silver Spring, MD USA
[3] US FDA, Off Clin Pharmacol, Off Translat Sci, Ctr Drug Evaluat & Res, Silver Spring, MD USA
[4] US FDA, Div Psychiat Prod, Off New Drugs, Ctr Drug Evaluat & Res, Silver Spring, MD USA
关键词
advanced age; Cockcroft-Gault; dosing; Modification of Diet in Renal Disease; pharmacokinetics; standardized serum creatinine assay; GLOMERULAR-FILTRATION-RATE; CREATININE CLEARANCE; IMPAIRMENT; PREVALENCE; VOLUNTEERS; METABOLISM; FORMULA; WEIGHT; ADULTS; DRUGS;
D O I
10.1345/aph.1Q757
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
BACKGROUND: The dosing of drugs in patients with kidney dysfunction is often based on the estimates of kidney function. OBJECTIVE: To systematically compare the performance of the Modification of Diet in Renal Disease (MDRD) and Cockcroft-Gault (CG) equations for dosage adjustment. METHODS: We assessed agreement (concordance, kappa statistics [kappa,kappa(omega)) between CG and MDRD using a Food and Drug Administration database to evaluate the effect of renal function on the pharmacokinetics of 36 approved drugs. Across the approved drugs, we compared the correlation between these 2 equations for renal drug clearance (Cl-ren) and area under the concentration-time curve. For 26 approved drugs that require renal dose adjustment, we also compared dosing regimens and expected exposure using these equations. Sensitivity analyses were performed by adjusting the MDRD estimates for individualized body surface area and/or range of serum creatinine assay calibration errors. RESULTS: In the pharmacokinetic database with 973 subjects (age 18-95 years, weight 35-153 kg, female 33%), we found that the CG and the MDRD classification of renal function generally agreed (64.2%, kappa = 0.54, kappa(omega) = 0.73). Among the subjects studied for drugs requiring renal dose adjustment, dosages in 12% were changed to a higher or lower dosing category by the MDRD compared to the CG equation. In particular, using MDRD in place of CG for dosage modification yielded higher dosing recommendations for subjects with a combination of age >80 years, weight <55 kg, and serum creatinine >0.7 and <= 1.5 mg/dL; the coefficient of determination was also higher by CG than MDRD in trials that enrolled these or similar patients. CONCLUSIONS: For patients with advanced age, low weight, and modestly elevated serum creatinine, further work is needed before the MDRD equations can replace the CG equation for dose adjustment in the labeling.
引用
收藏
页码:1174 / 1187
页数:14
相关论文
共 31 条
[1]  
[Anonymous], 2003, Statistical Methods for Rates and Proportions
[2]  
[Anonymous], KDOQI CLIN PRACT GUI
[3]   Nephropharmacology: Drugs and the Kidney [J].
Atkinson, A. J., Jr. ;
Huang, S-M .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 86 (05) :453-456
[4]  
Denetclaw Tina H, 2011, Ann Pharmacother, V45, pe44, DOI 10.1345/aph.1Q159
[5]  
*FDA GUID IND, 1998, PHARM PAT IMP REN FU
[6]  
Food and Drug Administration Clinical Pharmacology Guidances (Drugs), FOOD DRUG ADM CLIN P
[7]   Use of GFR equations to adjust drug doses in an elderly multi-ethnic group - a cautionary tale [J].
Gill, Jagbir ;
Malyuk, Rhonda ;
Djurdjev, Ognjenka ;
Levin, Adeera .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 (10) :2894-2899
[8]   Is modification of diet in renal disease formula similar to Cockcroft-Gault formula to assess renal function in elderly hospitalized patients treated with low-molecular-weight heparin? [J].
Gouin-Thibault, Isabelle ;
Pautas, Eric ;
Mahe, Isabelle ;
Descarpentries, Clotilde ;
Nivet-Antoine, Valerie ;
Golmard, Jean-Louis ;
Siguret, Virginie .
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2007, 62 (11) :1300-1305
[9]   Adjusting Eptifibatide Doses for Renal Impairment: A Model of Dosing Agreement Among Various Methods of Estimating Creatinine Clearance [J].
Healy, Martha F. ;
Speroni, Karen Gabel ;
Eugenio, Kenneth R. ;
Murphy, Patricia M. .
ANNALS OF PHARMACOTHERAPY, 2012, 46 (04) :477-483
[10]   When to Conduct a Renal Impairment Study During Drug Development: US Food and Drug Administration Perspective [J].
Huang, S-M ;
Temple, R. ;
Xiao, S. ;
Zhang, L. ;
Lesko, L. J. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 86 (05) :475-479